Translational cancer Research

Translational research at MOMA  integrates clinical specimens and clinical studies with in vitro studies and molecular models of colon, bladder, renal, prostate cancer, and endocrine diseases. MOMA is manifesting its international position by conducting translational research at a competitive level.

Comprehensive biobanks including detailed clinical follow-up are established and maintained by MOMA in close cooperation with clinicians

Research Aims

Molecular classification of patients in relation to disease stage, prognosis, outcome and treatment and insight into molecular pathways in subgroups of patients are desired. Bioinformatic modelling and large databases help to understand the importance of our molecular findings.

Modern technologies

MOMA uses advanced techniques and equipment for investigating gene expression, genomic instability, genomic variation, several RNA species and laser microdissected tissues, and for functional classification of early molecular changes and pathways.

MOMA has modern state-of.the-art laboratory facilities and access to the HPC facility at

Research groups

dyrskjøt group
bladder cancer
Link her
Lindbjerg Group
colorectal cancer
Link her
Sørensen group
prostate cancer
Link her
Link her
gravholt group
medical research
Link her
skou Pedersen Group
computational genomics & transcriptomics
Link her
Birkbak Group
cancer evolution
Link her
Besenbacher Group
computational genomics
Link her